Axiom Real-Time Metrics Inc. has sold its assets to Sitero Canada Inc. through a court-supervised process driven by a need for financial stability in a declining clinical trial market.
Target Information
Axiom Real-Time Metrics Inc. ("Axiom" or "the Company"), founded in 2001 and based in Ontario, Canada, specializes in providing eClinical solutions for small to medium-sized life science companies globally. The Company is known for its Fusion eClinical Suite, which features over 15 integrated modules such as Electronic Data Capture (EDC), Randomization & Trial Supply Management (RTSM), Clinical Trial Management Systems (CTMS), Electronic Patient-Reported Outcomes (ePRO), and Electronic Trial Master File (eTMF). This unified platform serves as the backbone of Axiom's clinical trial operations.
Despite having a robust operational history and a unique service portfolio, Axiom encountered significant macroeconomic challenges, notably a downturn in new clinical trials within the life sciences sector. In response to these pressures, the Company initiated various strategies aimed at operational efficiency and liquidity preservation.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The life sciences industry in Canada has demonstrated resilience, characterized by a strong focus on innovation and research. With numerous organizations dedicated to developing new therapeutics and technologies, the sector draws considerable investment.
Similar Deals
Nova Leap Health Corp. → two affiliated home care businesses and a home care business
2025
Sitero Canada Inc.
invested in
Axiom Real-Time Metrics Inc.
in 2025
in a Other deal